Guggenheim Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-14,548
Closed -$73K 1943
2020
Q2
$73K Sell
14,548
-3,324
-19% -$11.3K ﹤0.01% 1838
2020
Q1
$61K Sell
17,872
-13,976
-44% -$60.3K ﹤0.01% 1790
2019
Q4
$175K Sell
31,848
-2,452
-7% -$13.8K ﹤0.01% 2009
2019
Q3
$196K Sell
34,300
-1,943
-5% -$13.2K ﹤0.01% 2008
2019
Q2
$277K Sell
36,243
-803
-2% -$4.32K ﹤0.01% 1896
2019
Q1
$195K Buy
37,046
+2,008
+6% +$13.9K ﹤0.01% 2081
2018
Q4
$229K Buy
35,038
+5,169
+17% +$57.9K ﹤0.01% 2012
2018
Q3
$514K Buy
29,869
+12,200
+69% +$181K ﹤0.01% 1969
2018
Q2
$246K Buy
+17,669
New +$298K ﹤0.01% 2249
2017
Q4
Sell
-188,300
Closed -$3.58M 2786
2017
Q3
$3.58M Buy
188,300
+39,851
+27% +$820K 0.01% 1266
2017
Q2
$3.58M Sell
148,449
-3,010
-2% -$66K 0.01% 1213
2017
Q1
$3M Buy
151,459
+28,290
+23% +$632K 0.01% 1351
2016
Q4
$2.97M Sell
123,169
-22,167
-15% -$617K 0.01% 1378
2016
Q3
$4.04M Sell
145,336
-9,359
-6% -$247K 0.01% 1141
2016
Q2
$3.77M Buy
154,695
+27,189
+21% +$771K 0.01% 1145
2016
Q1
$4.28M Sell
127,506
-89,914
-41% -$2.83M 0.01% 1080
2015
Q4
$6.5M Sell
217,420
-33,128
-13% -$1.12M 0.02% 913
2015
Q3
$7.9M Sell
250,548
-70,430
-22% -$3.44M 0.02% 842
2015
Q2
$15.5M Sell
320,978
-4,694
-1% -$198K 0.04% 677
2015
Q1
$14.1M Buy
325,672
+77,710
+31% +$2.79M 0.03% 727
2014
Q4
$6.52M Buy
247,962
+35,487
+17% +$778K 0.02% 1010
2014
Q3
$3.77M Buy
212,475
+36,963
+21% +$755K 0.01% 1362
2014
Q2
$4.21M Sell
175,512
-20,849
-11% -$423K 0.01% 1288
2014
Q1
$4.93M Buy
+196,361
New +$5.44M 0.01% 1134

Other funds holding PGEN

Guggenheim Capital's PGEN Position: Q3 2020 in Review

Guggenheim Capital sold out of Precigen (PGEN) in Q3 2020, closing a stake of 14,548 shares — an estimated $73K sold.

Guggenheim Capital first reported a position in PGEN in Q1 2014 and held it in 24 quarters. The position peaked at $15.5M in Q2 2015. 159 funds tracked by Wall St. Rank hold PGEN as of Q3 2020.

  • Guggenheim Capital reported no remaining Precigen position as of Q3 2020 after selling out during the quarter.
  • Guggenheim Capital sold 14,548 Precigen shares in Q3 2020, an estimated $73K.
  • Guggenheim Capital first reported a position in Precigen in Q1 2014 and held it in 24 quarters.
  • Guggenheim Capital's Precigen position peaked at $15.5M in Q2 2015.
  • 159 funds tracked by Wall St. Rank held Precigen as of Q3 2020.

Based on Guggenheim Capital's 13F filing for Q3 2020, filed 13 Nov 2020.